BIOMET INC Research and Development Expense
BIOMET INC reported Research and Development Expense of $36.40 million for the 3-month period ending 2012-11-30, per its 10-Q filed 2013-01-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2013-01-14
- BIOMET INC research and development expense for the quarter ending 2012-11-30 was $36.40M, a 17.04% increase year-over-year.
- BIOMET INC research and development expense for the quarter ending 2012-08-31 was $35.80M, a 11.87% increase year-over-year.
- BIOMET INC research and development expense for the quarter ending 2012-05-31 was $33.60M, a 8.04% increase year-over-year.
- BIOMET INC research and development expense for the quarter ending 2012-02-29 was $30.10M, a 4.51% increase year-over-year.
- BIOMET INC research and development expense for fiscal 2012 was $126.80M, a 6.20% increase from fiscal 2011.
- BIOMET INC research and development expense for fiscal 2011 was $119.40M, a 12.01% increase from fiscal 2010.
- BIOMET INC research and development expense for fiscal 2010 was $106.60M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2012-11-30 | $36.40M 10-Q · filed 2013-01-14 | $72.20M 10-Q · filed 2013-01-14 | $105.80M derived: sum of 3 quarters · filed 2013-01-14 | $135.90M derived: sum of 4 quarters · filed 2013-01-14 |
| 2012-08-31 | $35.80M 10-Q · filed 2012-10-15 | $69.40M derived: sum of 2 quarters · filed 2012-10-15 | $99.50M derived: sum of 3 quarters · filed 2012-10-15 | $130.60M derived: sum of 4 quarters · filed 2013-01-14 |
| 2012-05-31 | $33.60M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-20 | $63.70M derived: sum of 2 quarters · filed 2012-08-20 | $94.80M derived: sum of 3 quarters · filed 2013-01-14 | $126.80M 10-K · filed 2012-08-20 |
| 2012-02-29 | $30.10M 10-Q · filed 2012-04-13 | $61.20M derived: sum of 2 quarters · filed 2013-01-14 | $93.20M 10-Q · filed 2012-04-13 | $124.30M derived: sum of 4 quarters · filed 2013-01-14 |
| 2011-11-30 | $31.10M 10-Q · filed 2013-01-14 | $63.10M 10-Q · filed 2013-01-14 | $94.20M derived: sum of 3 quarters · filed 2013-01-14 | $123.00M derived: sum of 4 quarters · filed 2013-01-14 |
| 2011-08-31 | $32.00M 10-Q · filed 2012-10-15 | $63.10M derived: sum of 2 quarters · filed 2012-10-15 | $91.90M derived: sum of 3 quarters · filed 2012-10-15 | $121.50M derived: sum of 4 quarters · filed 2012-10-15 |
| 2011-05-31 | $31.10M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-20 | $59.90M derived: sum of 2 quarters · filed 2012-08-20 | $89.50M derived: sum of 3 quarters · filed 2012-08-20 | $119.40M 10-K · filed 2012-08-20 |
| 2011-02-28 | $28.80M 10-Q · filed 2012-04-13 | $58.40M derived: sum of 2 quarters · filed 2012-04-13 | $88.30M 10-Q · filed 2012-04-13 | |
| 2010-11-30 | $29.60M 10-Q · filed 2012-01-13 | $59.50M 10-Q · filed 2012-01-13 | ||
| 2010-08-31 | $29.90M 10-Q · filed 2011-10-14 | |||
| 2010-05-31 | $106.60M 10-K · filed 2012-08-20 |